YourStory · Jun 2021
A Digi-Prex subsidiary, Good Health Clinic, raised $5.2M to expand categories and build out the team.
Subscription pharmacy for patients with chronic diseases
Company research
Public company, workplace, funding, and market signals
Overview
Digi-Prex is a Hyderabad-based healthtech / subscription pharmacy serving chronic-disease patients. It uses WhatsApp to receive prescriptions, delivers medicines monthly to the home, offers refill reminders and referral rewards, and claims pricing up to 15% below neighborhood pharmacies. Public employee and revenue estimates vary by source.
Primary product
Subscription pharmacy for chronic-disease medication delivery
Founded
2019
Headquarters
Hyderabad, Telangana, India
Team size
LinkedIn shows 10 employees (2026); Tracxn shows 26 employees as of 2026-05-31
Industry
Hospitals and Health Care
Sub-industry
Chronic disease management / online subscription pharmacy
Offices
Hyderabad, Telangana, India
San Francisco, California, United States
Business model
subscription pharmacy
direct-to-consumer medicine delivery
AI-assisted chronic disease management
Funding
Stage
Seed
Total raised
$5.8M
Latest round
Seed · Sep 2019
Latest amount
$5.5M
People & investors
Work & culture
Compensation
No public company salary band was found. Public compensation signals include Salary.com’s U.S. estimate of about $119.8k/year and a 2022 H-1B filing reported by MyVisaJobs with a $175k offered salary for a Digi-Prex CEO role.
Product & market
Pricing
Monthly subscription model; medicines claimed to be up to 15% cheaper than neighborhood pharmacies, with free home delivery and referral credits.
Differentiators
- —WhatsApp-based prescription intake
- —monthly refill subscription
- —automatic refill reminders
- —free home delivery
- —AI-driven lifestyle management
- —personalized interactions
- —referral rewards
Technology
Figma
Impact
Sketch
Customers
patients with chronic diseases
subscription pharmacy users in India
patients needing regular medication delivery
Competitors
Practo
NetMeds
1mg
PharmEasy
SastaSundar
API Holdings
MedPlus
Scale & contact
Estimated revenue
₹0–10 Cr INR (Tracxn, as of 2025-03-31); GetLatka estimates ~$4.8M ARR in 2024
Estimated monthly visits
898
Traffic estimate as of Jun 2026
Latest news
KR Asia · Sep 2019
Covers the seed round and the company’s plan to expand to additional Indian cities.
Inc42 · Sep 2019
Confirms the seed round and lists investors including Khosla Ventures, Y Combinator, Quiet Capital, SV Angel, and Justin Mateen.
TechCrunch · Sep 2019
Digi-Prex raised a $5.5M seed round and used WhatsApp-based prescription sharing to serve chronic-disease patients.
YourStory · Sep 2019
Reports the $5.5M seed round, Y Combinator Demo Day participation, and expansion plans across India.
Jobs and careers at Digi-Prex
0 jobs at Digi-Prex
No open positions
Check back later for new openings